RT Journal Article
SR Electronic
T1 The relevance of rich club regions for functional outcome post-stroke is enhanced in women
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.28.22277020
DO 10.1101/2022.06.28.22277020
A1 Bonkhoff, Anna K.
A1 Schirmer, Markus D.
A1 Bretzner, Martin
A1 Hong, Sungmin
A1 Regenhardt, Robert W.
A1 Donahue, Kathleen L.
A1 Nardin, Marco J.
A1 Dalca, Adrian V.
A1 Giese, Anne-Katrin
A1 Etherton, Mark R.
A1 Hancock, Brandon L.
A1 Mocking, Steven J. T.
A1 McIntosh, Elissa C.
A1 Attia, John
A1 Cole, John W.
A1 Donatti, Amanda
A1 Griessenauer, Christoph J.
A1 Heitsch, Laura
A1 Holmegaard, Lukas
A1 Jood, Katarina
A1 Jimenez-Conde, Jordi
A1 Kittner, Steven J.
A1 Lemmens, Robin
A1 Levi, Christopher R.
A1 McDonough, Caitrin W.
A1 Meschia, James F.
A1 Phuah, Chia-Ling
A1 Ropele, Stefan
A1 Rosand, Jonathan
A1 Roquer, Jaume
A1 Rundek, Tatjana
A1 Sacco, Ralph L.
A1 Schmidt, Reinhold
A1 Sharma, Pankaj
A1 Slowik, Agnieszka
A1 Sousa, Alessandro
A1 Stanne, Tara M.
A1 Strbian, Daniel
A1 Tatlisumak, Turgut
A1 Thijs, Vincent
A1 Vagal, Achala
A1 Wasselius, Johan
A1 Woo, Daniel
A1 Zand, Ramin
A1 McArdle, Patrick F.
A1 Worrall, Bradford B.
A1 Jern, Christina
A1 Lindgren, Arne G.
A1 Maguire, Jane
A1 Wu, Ona
A1 Rost, Natalia S.
A1 the MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium
YR 2022
UL http://medrxiv.org/content/early/2022/06/29/2022.06.28.22277020.abstract
AB This study aimed to investigate the influence of stroke lesions in pre-defined highly interconnected (rich club) brain regions on functional outcome post-stroke, determine their spatial specificity and explore the effects of biological sex on their relevance.We analyzed MRI data recorded at index stroke and ∼3-months modified Rankin Scale (mRS) data from patients with acute ischemic stroke (AIS) enrolled in the multisite MRI-GENIE study. Structural stroke lesions were spatially normalized and parcellated into 108 atlas-defined bilateral (sub)cortical brain regions. Unfavorable outcome (mRS>2) was modeled in a Bayesian logistic regression framework that relied on both lesion location, as well as the covariates: age, sex, total DWI lesion volume and comorbidities. Effects of individual brain regions were captured as two compound effects for (i) six bilateral rich club and (ii) all further non-rich club regions. Via model comparisons, we first tested whether the rich club region model was superior to a baseline model considering clinical covariates and lesion volume only. In spatial specificity analyses, we randomized the split into “rich club” and “non-rich club” regions and compared the effect of the actual rich club regions to the distribution of effects from 1,000 combinations of six random regions. In sex-specific analyses, we introduced an additional hierarchical level in our model structure to compare male and female-specific rich club region effects.A total of 822 patients (age: 64.7 (standard deviation: 15.0), 39% women, 27.7% with mRS>2) were analyzed. The rich club model substantially outperformed the baseline model (weights of model comparison: rich club model: 0.96; baseline: 0.04). Rich club regions had substantial relevance in explaining unfavorable functional outcome (mean of posterior distribution: 0.08, area under the curve: 0.8). In particular, the rich club-combination had a higher relevance than 98.4% of random constellations (15/1,000 random constellations with higher mean posterior values). Among the these 15 random constellations with higher means, the most frequently selected regions were the inferior temporal gyrus (posterior division, 8/15), the putamen (8/15), the cingulate gyrus (7/15) and the superior parietal lobule (6/15). Rich club regions were substantially more important in explaining long-term outcome in women than in men (mean of the difference distribution:-0.107, 90%-HDPI:-0.193 to -0.0124).Lesions in rich club regions were associated with increased odds of unfavorable outcome. These effects were spatially specific, i.e., the majority of random combinations of six regions had comparably smaller effects on long-term outcome. Effects were substantially more pronounced in women.Competing Interest StatementM.E. has received personal fees for consulting from Astra Zeneca and WorldCare Clinical Group. C.G. has received consulting honoraria from Microvention and Strykere and research funding from Medtronic and Penumbra. A.V. has received research funding from Cerenovus. A.G.L. reports personal fees from Bayer, NovoNordisk, Astra Zeneca, and BMS Pfizer outside this work. T.T. has served/serves on scientific advisory boards for Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Inventiva, Portola Pharm, and PHRI; has/ has had research contracts with Bayer, Boehringer Ingelheim, and Bristol Myers Squibb. N.S.R. has received compensation as scientific advisory consultant from Omniox, Sanofi Genzyme and AbbVie Inc.Funding StatementA.K.B. is supported by a MGH ECOR Fund for Medical Discovery (FMD) Clinical Research Fellowship Award. M.B. acknowledges support from the Societe Francaise de Neuroradiologie, Societe Francaise de Radiologie, Fondation ISITE-ULNE. A.V. is in part supported by NIH-NINDS (R01 NS103824, RF1 NS117643, R01 NS100417, U01NS100699, U01NS110772). C.J. acknowledges support from the Swedish Research Council (2021-01114), the Swedish state under the agreement between the Swedish government and the county councils, the Avtal om Lakarutbildning och Medicinsk Forskning (ALF) agreement (ALFGBG-965328); the Swedish Heart and Lung Foundation (20190203). A.G.L. is funded by: The Swedish Research Council (2019-01757), The Swedish Government (under the Avtal om Lakarutbildning och Medicinsk Forskning, ALF), The Swedish Heart and Lung Foundation, The Swedish Stroke Association, Region Skane, Lund University, Skane University Hospital, Sparbanksstiftelsen Fars och Frosta, Fremasons Lodge of Instruction Eos in Lund. N.S.R. is in part supported by NIH-NINDS (R01NS082285, R01NS086905, U19NS115388).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All subjects gave written informed consent in accordance with the Declaration of Helsinki. The study protocol was approved by Massachusetts General Hospital's Institutional Review Board (Protocol #: 2001P001186 and 2003P000836) and Review Boards of individual sites.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors agree to make the data available to any researcher for the express purposes of reproducing the here presented results and with the explicit permission for data sharing by individual sites' institutional review boards.